Nutraceutical CDMO Market

Table of Content

1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand Side Trends
    1.3. Supply-Side Trends
    1.4. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
    2.3. Inclusions and Exclusions
3. Key Market Trends
    3.1. Key Trends Impacting the Market
4. Value Added Insights
    4.1. Service Adoption, By Region
    4.2. Overview of CRO and CDMO Services
    4.3. Role of Contract Service Providers
    4.4. Regulatory Scenario, By Country
    4.5. Industry Deals
    4.6. PESTEL Analysis by Region
    4.7. PORTER Analysis
5. Market Background
    5.1. Macro-Economic Factors
        5.1.1. Global Healthcare Expenditure Outlook
        5.1.2. Global R&D Funding Outlook
        5.1.3. Global Life Expectancy Outlook
        5.1.4. Growing Geriatric Population
    5.2. Forecast Factors - Relevance & Impact
        5.2.1. Increase in R&D Funding and Grants
        5.2.2. Increasing Adoption of Nutraceutical Products
        5.2.3. Product Pipeline
        5.2.4. Product Innovation Trends
        5.2.5. Market Consolidation Activities
        5.2.6. Prevalence of Chronic Diseases
        5.2.7. Shift Towards Technologically Advanced Products
    5.3. Market Dynamics
        5.3.1. Drivers
        5.3.2. Restraints
        5.3.3. Opportunity Analysis
6. Global Market Demand (in Value or Size in US$ million) Analysis 2019 to 2023 and Forecast, 2024 to 2034
    6.1. Historical Market Value (US$ million) Analysis, 2019 to 2023
    6.2. Current and Future Market Value (US$ million) Projections, 2024 to 2034
        6.2.1. Y-o-Y Growth Trend Analysis
        6.2.2. Absolute $ Opportunity Analysis
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
    7.1. Introduction / Key Findings
    7.2. Historical Market Size (US$ million) By Dosage Form, 2019 to 2023
    7.3. Current and Future Market Size (US$ million) Analysis and Forecast By Dosage Form, 2024 to 2034
        7.3.1. Tablets & Capsules
        7.3.2. Powder
        7.3.3. Softgel
        7.3.4. Liquid Formulations
        7.3.5. Others (Gummies, Sprays, Sachets, Topical Forms)
    7.4. Market Attractiveness Analysis By Dosage Form
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
    8.1. Introduction / Key Findings
    8.2. Historical Market Size (US$ million) Analysis By Services, 2019 to 2023
    8.3. Current and Future Market Size (US$ million) Analysis and Forecast By Services, 2024 to 2034
        8.3.1. Product Formulation and Development
        8.3.2. Manufacturing and Packaging
        8.3.3. Research and Development
        8.3.4. Analytical and Testing Services
        8.3.5. Regulatory Support
    8.4. Market Attractiveness Analysis By Services
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
    9.1. Introduction / Key Findings
    9.2. Historical Market Size (US$ million) By Company Size, 2019 to 2023
    9.3. Current and Future Market Size (US$ million) Analysis and Forecast By Company Size, 2024 to 2034
        9.3.1. Small Companies
        9.3.2. Mid-sized Companies
        9.3.3. Large Companies
    9.4. Market Attractiveness Analysis By Company Size
10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
    10.1. Introduction / Key Findings
    10.2. Historical Market Size (US$ million) Analysis By Region, 2019 to 2023
    10.3. Current and Future Market Size (US$ million) Analysis and Forecast By Region, 2024 to 2034
        10.3.1. North America
        10.3.2. Latin America
        10.3.3. East Asia
        10.3.4. South Asia & Pacific
        10.3.5. Western Europe
        10.3.6. Eastern Europe
        10.3.7. Middle East & Africa
    10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
    11.1. Introduction
    11.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2023
    11.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
        11.3.1. By Country
            11.3.1.1. United States
            11.3.1.2. Canada
            11.3.1.3. Mexico
        11.3.2. By Dosage Form
        11.3.3. By Services
        11.3.4. By Company Size
    11.4. Market Attractiveness Analysis
        11.4.1. By Country
        11.4.2. By Dosage Form
        11.4.3. By Services
        11.4.4. By Company Size
    11.5. Country Level Analysis & Forecast
        11.5.1. United States Market Analysis
            11.5.1.1. Introduction
            11.5.1.2. Market Analysis and Forecast by Market Taxonomy
                11.5.1.2.1. By Dosage Form
                11.5.1.2.2. By Services
                11.5.1.2.3. By Company Size
        11.5.2. Canada Market Analysis
            11.5.2.1. Introduction
            11.5.2.2. Market Analysis and Forecast by Market Taxonomy
                11.5.2.2.1. By Dosage Form
                11.5.2.2.2. By Services
                11.5.2.2.3. By Company Size
        11.5.3. Mexico Market Analysis
            11.5.3.1. Introduction
            11.5.3.2. Market Analysis and Forecast by Market Taxonomy
                11.5.3.2.1. By Dosage Form
                11.5.3.2.2. By Services
                11.5.3.2.3. By Company Size
12. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
    12.1. Introduction
    12.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2023
    12.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
        12.3.1. By Country
            12.3.1.1. Brazil
            12.3.1.2. Chile
            12.3.1.3. Rest of Latin America
        12.3.2. By Dosage Form
        12.3.3. By Services
        12.3.4. By Company Size
    12.4. Market Attractiveness Analysis
        12.4.1. By Country
        12.4.2. By Dosage Form
        12.4.3. By Services
        12.4.4. By Company Size
    12.5. Market Trends
    12.6. PESTEL Analysis
    12.7. Key Market Participants - Intensity Mapping
    12.8. Drivers and Restraints - Impact Analysis
    12.9. Country Level Analysis & Forecast
        12.9.1. Brazil Market Analysis
            12.9.1.1. Introduction
            12.9.1.2. Market Analysis and Forecast by Market Taxonomy
                12.9.1.2.1. By Dosage Form
                12.9.1.2.2. By Services
                12.9.1.2.3. By Company Size
        12.9.2. Chile Market Analysis
            12.9.2.1. Introduction
            12.9.2.2. Market Analysis and Forecast by Market Taxonomy
                12.9.2.2.1. By Dosage Form
                12.9.2.2.2. By Services
                12.9.2.2.3. By Company Size
13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034
    13.1. Introduction
    13.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2023
    13.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
        13.3.1. By Country
            13.3.1.1. China
            13.3.1.2. Japan
            13.3.1.3. South Korea
        13.3.2. By Dosage Form
        13.3.3. By Services
        13.3.4. By Company Size
    13.4. Market Attractiveness Analysis
        13.4.1. By Country
        13.4.2. By Dosage Form
        13.4.3. By Services
        13.4.4. By Company Size
    13.5. Country Level Analysis & Forecast
        13.5.1. China Market Analysis
            13.5.1.1. Introduction
            13.5.1.2. Market Analysis and Forecast by Market Taxonomy
                13.5.1.2.1. By Dosage Form
                13.5.1.2.2. By Services
                13.5.1.2.3. By Company Size
        13.5.2. Japan Market Analysis
            13.5.2.1. Introduction
            13.5.2.2. Market Analysis and Forecast by Market Taxonomy
                13.5.2.2.1. By Dosage Form
                13.5.2.2.2. By Services
                13.5.2.2.3. By Company Size
        13.5.3. South Korea Market Analysis
            13.5.3.1. Introduction
            13.5.3.2. Market Analysis and Forecast by Market Taxonomy
                13.5.3.2.1. By Dosage Form
                13.5.3.2.2. By Services
                13.5.3.2.3. By Company Size
14. South Asia & Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034
    14.1. Introduction
    14.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2023
    14.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
        14.3.1. By Country
            14.3.1.1. India
            14.3.1.2. ASEAN Countries
            14.3.1.3. Australia & New Zealand
            14.3.1.4. Rest of South Asia and Pacific
        14.3.2. By Dosage Form
        14.3.3. By Services
        14.3.4. By Company Size
    14.4. Market Attractiveness Analysis
        14.4.1. By Country
        14.4.2. By Dosage Form
        14.4.3. By Services
        14.4.4. By Company Size
    14.5. Country Level Analysis & Forecast
        14.5.1. India Market Analysis
            14.5.1.1. Introduction
            14.5.1.2. Market Analysis and Forecast by Market Taxonomy
                14.5.1.2.1. By Dosage Form
                14.5.1.2.2. By Services
                14.5.1.2.3. By Company Size
        14.5.2. ASEAN Countries Market Analysis
            14.5.2.1. Introduction
            14.5.2.2. Market Analysis and Forecast by Market Taxonomy
                14.5.2.2.1. By Dosage Form
                14.5.2.2.2. By Services
                14.5.2.2.3. By Company Size
        14.5.3. Australia & New Zealand Market Analysis
            14.5.3.1. Introduction
            14.5.3.2. Market Analysis and Forecast by Market Taxonomy
                14.5.3.2.1. By Dosage Form
                14.5.3.2.2. By Services
                14.5.3.2.3. By Company Size
15. Western Europe Market 2019-2022 and Forecast 2024 to 2034
    15.1. Introduction
    15.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2023
    15.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
        15.3.1. By Country
            15.3.1.1. Germany
            15.3.1.2. Italy
            15.3.1.3. France
            15.3.1.4. United Kingdom
            15.3.1.5. Spain
            15.3.1.6. BENELUX
            15.3.1.7. Rest of Western Europe
        15.3.2. By Dosage Form
        15.3.3. By Services
        15.3.4. By Company Size
    15.4. Market Attractiveness Analysis
        15.4.1. By Country
        15.4.2. By Dosage Form
        15.4.3. By Services
        15.4.4. By Company Size
    15.5. Country Level Analysis & Forecast
        15.5.1. Germany Market Analysis
            15.5.1.1. Introduction
            15.5.1.2. Market Analysis and Forecast by Market Taxonomy
                15.5.1.2.1. By Dosage Form
                15.5.1.2.2. By Services
                15.5.1.2.3. By Company Size
        15.5.2. France Market Analysis
            15.5.2.1. Introduction
            15.5.2.2. Market Analysis and Forecast by Market Taxonomy
                15.5.2.2.1. By Dosage Form
                15.5.2.2.2. By Services
                15.5.2.2.3. By Company Size
        15.5.3. Spain Market Analysis
            15.5.3.1. Introduction
            15.5.3.2. Market Analysis and Forecast by Market Taxonomy
                15.5.3.2.1. By Dosage Form
                15.5.3.2.2. By Services
                15.5.3.2.3. By Company Size
        15.5.4. Italy Market Analysis
            15.5.4.1. Introduction
            15.5.4.2. Market Analysis and Forecast by Market Taxonomy
                15.5.4.2.1. By Dosage Form
                15.5.4.2.2. By Services
                15.5.4.2.3. By Company Size
        15.5.5. BENELUX Market Analysis
            15.5.5.1. Introduction
            15.5.5.2. Market Analysis and Forecast by Market Taxonomy
                15.5.5.2.1. By Dosage Form
                15.5.5.2.2. By Services
                15.5.5.2.3. By Company Size
        15.5.6. United Kingdom Market Analysis
            15.5.6.1. Introduction
            15.5.6.2. Market Analysis and Forecast by Market Taxonomy
                15.5.6.2.1. By Dosage Form
                15.5.6.2.2. By Services
                15.5.6.2.3. By Company Size
16. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034
    16.1. Introduction
    16.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2023
    16.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
        16.3.1. By Country
            16.3.1.1. Russia
            16.3.1.2. Hungary
            16.3.1.3. Poland
            16.3.1.4. Rest of Eastern Europe
        16.3.2. By Dosage Form
        16.3.3. By Services
        16.3.4. By Company Size
    16.4. Market Attractiveness Analysis
        16.4.1. By Country
        16.4.2. By Dosage Form
        16.4.3. By Services
        16.4.4. By Company Size
    16.5. Country Level Analysis & Forecast
        16.5.1. Russia Market Analysis
            16.5.1.1. Introduction
            16.5.1.2. Market Analysis and Forecast by Market Taxonomy
                16.5.1.2.1. By Dosage Form
                16.5.1.2.2. By Services
                16.5.1.2.3. By Company Size
        16.5.2. Hungary Market Analysis
            16.5.2.1. Introduction
            16.5.2.2. Market Analysis and Forecast by Market Taxonomy
                16.5.2.2.1. By Dosage Form
                16.5.2.2.2. By Services
                16.5.2.2.3. By Company Size
        16.5.3. Poland Market Analysis
            16.5.3.1. Introduction
            16.5.3.2. Market Analysis and Forecast by Market Taxonomy
                16.5.3.2.1. By Dosage Form
                16.5.3.2.2. By Services
                16.5.3.2.3. By Company Size
17. Middle East & Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034
    17.1. Introduction
    17.2. Historical Market Size (US$ million) Analysis by Market Taxonomy, 2019 to 2023
    17.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
        17.3.1. By Country
            17.3.1.1. Saudi Arabia
            17.3.1.2. Türkiye
            17.3.1.3. South Africa
            17.3.1.4. Other African Union
            17.3.1.5. Rest of Middle East & Africa
        17.3.2. By Dosage Form
        17.3.3. By Services
        17.3.4. By Company Size
    17.4. Market Attractiveness Analysis
        17.4.1. By Country
        17.4.2. By Dosage Form
        17.4.3. By Services
        17.4.4. By Company Size
    17.5. Country Level Analysis & Forecast
        17.5.1. Saudi Arabia Market Analysis
            17.5.1.1. Introduction
            17.5.1.2. Market Analysis and Forecast by Market Taxonomy
                17.5.1.2.1. By Dosage Form
                17.5.1.2.2. By Services
                17.5.1.2.3. By Company Size
        17.5.2. Türkiye Market Analysis
            17.5.2.1. Introduction
            17.5.2.2. Market Analysis and Forecast by Market Taxonomy
                17.5.2.2.1. By Dosage Form
                17.5.2.2.2. By Services
                17.5.2.2.3. By Company Size
        17.5.3. South Africa Market Analysis
            17.5.3.1. Introduction
            17.5.3.2. Market Analysis and Forecast by Market Taxonomy
                17.5.3.2.1. By Dosage Form
                17.5.3.2.2. By Services
                17.5.3.2.3. By Company Size
        17.5.4. Other African Union Market Analysis
            17.5.4.1. Introduction
            17.5.4.2. Market Analysis and Forecast by Market Taxonomy
                17.5.4.2.1. By Dosage Form
                17.5.4.2.2. By Services
                17.5.4.2.3. By Company Size
18. Market Structure Analysis
    18.1. Market Analysis by Tier of Companies
    18.2. Market Share Analysis of Top Companies
    18.3. Market Presence Analysis
19. Competition Analysis
    19.1. Competition Benchmarking
    19.2. Competition Dashboard
    19.3. Key Development Analysis
    19.4. Key Promotional Strategies, By Manufacturers
    19.5. Competition Deep Dive
        19.5.1. Catalent, Inc.
            19.5.1.1. Overview
            19.5.1.2. Service Portfolio
            19.5.1.3. Sales Footprint
            19.5.1.4. Key Financials
            19.5.1.5. Key Developments
            19.5.1.6. Strategy Overview
            19.5.1.7. SWOT Analysis
        19.5.2. Lonza
        19.5.3. Aenova Group
        19.5.4. Akums Drugs and Pharmaceutical Ltd.
        19.5.5. BASF SE
        19.5.6. Sirio Pharma
        19.5.7. Pharmavite LLC
        19.5.8. Nature's Products, Inc.
        19.5.9. PLT Health Solutions
        19.5.10. Glanbia Nutritionals
        19.5.11. Recipharm AB
        19.5.12. B&D Nutritional Ingredients
        19.5.13. NutraScience Labs
        19.5.14. Vitakem Nutraceutical Inc.
        19.5.15. Softigel (A division of Procaps Group)
        19.5.16. Iprona AG
        19.5.17. Nutrilo GmbH
        19.5.18. Atlantic Essential Products, Inc.
        19.5.19. ProTec Nutra Ltd.
        19.5.20. Nutraceuticals International Group
20. Assumptions and Acronyms Used
21. Research Methodology